Statins can lower the risk of developing dementia by up to 15%, with earlier treatment yielding the highest protection, according to a 15-year study presented at the European Society of Cardiology (ESC) annual congress in Munich and published in the Lancet Regional Health Europe journal. The research tracked more than 132,000 people in Denmark between 2006 and 2021, offering new data on how cholesterol-lowering drugs intersect with long-term brain health as global dementia cases are forecast to near 153 million by 2050.
How Statins and Cholesterol Impact Brain Health
Statins work by reducing low-density lipoprotein (LDL) cholesterol levels in the blood, which prevents plaque buildup in arteries and lowers the risk of heart attacks and strokes. According to Dr Tummas Ternhamar from Copenhagen University hospital, who presented the findings, high LDL cholesterol can harden or narrow the blood vessels supplying the brain, driving plaque formation and disrupting blood flow. By targeting this risk factor from midlife, researchers suggest the cardiovascular benefits extend directly to neurological protection. Prof Isabel Goncalves of the ESC communication committee noted that because statins are widely available and inexpensive, these findings carry significant potential.
Did you know? While around eight million people in the UK take statins, at least twice as many are believed to already be eligible.
Early Intervention vs. Late Treatment in Dementia Risk
Timing plays a critical role in how effectively the medication lowers neurological risk. In the Danish study of 132,585 individuals all diagnosed with type 2 diabetes, participants who started statin therapy early experienced a 15% lower relative risk of dementia over 10 years compared to those who took no statins. Those who initiated treatment later saw a 10% reduction in relative risk over the same period, with results proving consistent across both men and women. Dr Ternhamar emphasized that tackling dementia requires addressing multiple factors simultaneously, placing cholesterol management alongside physical activity and healthy eating.
Pro tip: Medical experts recommend discussing cardiovascular risk profiles with a primary care clinician to determine the appropriate timing for cholesterol management interventions.
Broader Cardiovascular and Neurological Trials
The Munich conference also highlighted separate international research regarding older demographics. Dr Honorine Lebraud of Alzheimer’s Research UK noted that while observational studies like the Danish trial cannot definitively prove a direct causative link between statins and reduced dementia risk, they reinforce the principle that “what is good for the heart is good for the brain.” Prof Bryan Williams, chief scientific and medical officer of the British Heart Foundation, added that trial evidence showing statins reduce dementia risk makes these observational findings entirely plausible.
Frequently Asked Questions
Do statins prevent dementia entirely?
Statins do not prevent dementia entirely, but observational research presented at the European Society of Cardiology congress indicates they are associated with a 10% to 15% lower relative risk of developing the condition.
Why do statins affect the brain?
Experts believe that lowering LDL cholesterol prevents hardening and narrowing of the blood vessels that supply the brain, thereby protecting against reduced blood flow and tissue damage.
Does the timing of statin use matter?
Yes. Data from Copenhagen University hospital suggests that starting statin therapy earlier in life provides a higher chance of avoiding dementia compared to late initiation.
Are statins prescribed exclusively for heart health?
Historically prescribed to lower cholesterol and prevent heart attacks and strokes, ongoing research suggests their protective vascular effects may also benefit long-term neurological health.
Join the discussion: What are your thoughts on integrating cardiovascular treatments into long-term neurological care? Share your perspective in the comments below, explore our related health coverage, or subscribe to our newsletter for the latest medical research updates.
Related reading